Sree Kasichayanula, PhD

Sr Director
Gilead Sciences, Inc.

Sree Kasichayanula is currently a Senior Director at Gilead Sciences where he is responsible for leading the Clinical Pharmacology efforts for IO therapies. Prior to joining Gilead, Sree was Clin Pharm site head at AbbVie in Redwood City. Sree has also worked at Amgen and BMS across various therapeutic areas and different modalities.

Sree has an extensive presentation and publication record at various clinical and clinical pharmacology meetings and journals and has served on various committees of ACCP and ASCPT

Disclosure information not submitted.

Presentation(s):

• Leveraging Early Markers of Tumor Response in Model-Informed Drug Development to Aid in Go/No-Go Decisions: Are We There Yet?

  Thursday, March 17, 2022
  12:15 PM – 1:15 PM ET